Exploring the Cost-Utility of a Biomarker Predicting Persistent Severe Acute Kidney Injury: The Case of C-C Motif Chemokine Ligand 14 (CCL14)

Exploring the Cost-Utility of a Biomarker Predicting Persistent Severe Acute Kidney Injury: The Case of C-C Motif Chemokine Ligand 14 (CCL14)

Jorge Echeverri,1 Rui Martins,2,3 Kai Harenski,4 J Patrick Kampf,5 Paul McPherson,5 Julien Textoris,6,7 Jay L Koyner8 1Global Medical Affairs, Baxter Healthcare Corporation, Deerfield, IL, USA; 2University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; 3Health Economi...

Full description

Bibliographic Details
Main Authors: Echeverri J, Martins R, Harenski K, Kampf JP, McPherson P, Textoris J, Koyner JL
Format: Article
Language:English
Published: Dove Medical Press 2024-01-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
acute kidney injury
dialysis
biomarkers
nephrology
cost effectiveness.
Online Access:https://www.dovepress.com/exploring-the-cost-utility-of-a-biomarker-predicting-persistent-severe-peer-reviewed-fulltext-article-CEOR

Internet

https://www.dovepress.com/exploring-the-cost-utility-of-a-biomarker-predicting-persistent-severe-peer-reviewed-fulltext-article-CEOR

Similar Items